The analysis of mRNA expression showed that AEBP1 was upregulated in the AD patients, whereas AK5, COPG2IT1, CARTPT, and NPTX2 were downregulated in AD patients (Fig. 9A). The gene discussed is NPTX2; the disease is Alzheimer disease.